ICICI Prudential Nifty Pharma ETF
ICICI Prudential Nifty Pharma ETF portfolio holdings, Oct 2026: 20 stocks, ₹6.5 cr in listed equity, from ICICI Prudential Mutual Fund's monthly disclosure.
The scheme's yearly running cost as a % of its assets, taken out of the NAV a little each day. A regular plan costs more: it pays a distributor's commission.
Category median: direct 0.50 %, regular 0.69 % (27 schemes)
Of this, the base expense ratio, the part SEBI caps: regular 0.21 %. The rest is brokerage, transaction costs and statutory levies such as GST and STT, as AMFI's file lists them.
A year, as of 12 Nov 2026. Source: AMFI · Glossary: TER
20 stocks, Oct 2026.
As the AMC's file prints % of NAV. The top 10 stocks together: 78.6%.
This month: Oct 2026
first month collectedMoves, Oct 2026
How many stocks the scheme bought into, added to, cut or sold out of this month, by share count, so a price move alone never counts.
- New—
- Added—
- Trimmed—
- Exited—
Asset mix, Oct 2026
How much of the fund sits in listed shares; the rest is foreign shares, debt, money market, cash and other assets.
- Listed equity100.0%
- Rest, not itemised0.0%
Rest = foreign shares, debt, money market, cash, REIT/InvIT units and other assets.
Sectors and top 10, Oct 2026
Sector mix, Oct 2026
How the scheme's equity is spread across sectors at month end.
- 100.0%
AMFI's 22 sectors; one sector per stock, from the fund houses' industry labels.
Large, mid and small cap, Oct 2026
How the scheme's equity splits across large, mid and small companies, on AMFI's list.
- Mid Cap47.1%
- Large Cap45.3%
- Small Cap7.6%
AMFI's list of Jun 2026.
Top 10 holdings
Its ten largest stocks, each as a share of the fund.
- 18.62%
- 12.29%
- 9.27%
- 8.15%
- 7.67%
- 6.71%
- 4.83%
- 4.60%
- 3.42%
- 3.05%
As the AMC's file prints % of NAV.
Show all 20 stocksShow the first 15
Equity rows as disclosed, Oct 2026. Source: ICICI Prudential Mutual Fund monthly portfolio. Report a wrong number
Large, mid and small caps, % of net assets, last 12 months
AMFI list in force each month
| Month | Large | Mid | Small | Not in AMFI's list | AMFI list |
|---|---|---|---|---|---|
| Oct 2026 | 45.3% | 47.1% | 7.6% | 0.0% | Jun 2026 |
Equity holdings' % of net assets each month, by AMFI's cap list in force that month.
Portfolio turnover, from holdings
equity only · month-end snapshots
| Month | Bought | Sold | Turnover |
|---|---|---|---|
| Oct 2026 | — | — | — |
The lower of bought and sold over the average equity value, from month-end holdings; it can differ from the fund house's own figure.
| Period | Return | From | To |
|---|---|---|---|
| Since first NAV | +10.73 % in total | 26 Oct 2026 · NAV ₹25.7617 | 13 Nov 2026 · NAV ₹28.5248 |
Past performance may not be sustained in future.
Change in the plan's NAV between the two dates shown, as AMFI publishes the NAVs (plan code 154804).
Not enough NAV history stored yet for rolling returns, calendar-year returns and a monthly SIP.
Tracking error and tracking difference
index fund / ETF · as published by AMFI
| Tracking difference, Oct 2026 | Direct plan | Regular plan |
|---|---|---|
| Since launch | — | −0.13 % |
As AMFI publishes them against Nifty Pharma TRI. Source: AMFI tracking error and tracking difference. How to read
Embed this card
Copy this into any web page. The image carries its source, date and a link back; it is redrawn each night.
- 5 Nov 2026 · TER change: ICICI Prudential Nifty Pharma ETF: AMFI TER file of 5 Nov 2026: regular plan 5.74% (was 0.25%); previous file 31 Oct 2026
- 26 Oct 2026 · New scheme: ICICI Prudential Nifty Pharma ETF: first NAV in AMFI's NAV history ₹25.7617 on 26 Oct 2026 (ICICI Prudential Nifty Pharma ETF); launch date 12 Oct 2026 in AMFI scheme data
From AMFI's own files (scheme summary documents, NAV history, TER), as they stood on the day shown.
Questions about ICICI Prudential Nifty Pharma ETF
from the figures on this pageWhat are the top holdings of ICICI Prudential Nifty Pharma ETF?
At Oct 2026 end, ICICI Prudential Nifty Pharma ETF held 20 stocks (100.0% of the fund in equity). Largest: Sun Pharmaceutical Industries 18.62%, Divi's Laboratories 12.29%, Laurus Labs 9.27%, Dr. Reddy's Laboratories 8.15%, Cipla 7.67%; the top 10 make up 78.6%. Funds holding Sun Pharmaceutical Industries · Funds holding Divi's Laboratories · Funds holding Laurus Labs
All schemes of ICICI Prudential Mutual Fund →
Mutual fund investments are subject to market risks; read all scheme related documents carefully.